Company intelligence / Profile preview

Pappas Ventures

Durham, North Carolina, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Pappas Ventures is a leading venture capital firm specializing in early and growth-stage investments in life sciences, backing companies with novel biotechnologies and innovative healthcare products; over 100 companies funded, with 40 IPOs/M&A, and >4 companies exited at $1B+[1][2][3][8].

Modalities: Small moleculeGene therapyBiologicMonoclonal antibodyAntibody-drug conjugateRNA therapyMedical deviceDiagnostics
Industry: Investors

Partnerships

SAS (analytics partnership in AgTech[6])Research universities for translational medicine funds[7]

Beyond the preview

Go deeper on Pappas Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pappas Ventures.

Explore the full profile